Avita Medical Ltd – Strategy, SWOT and Corporate Finance Report

Avita Medical Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Avita Medical Ltd (Avita Medical) is a medical device company that develops and distributes regenerative, tissue-engineered products for treating burns, scars, wounds, and skin defects. The company’s medical device portfolio includes ReCell for the treatment of burns and plastic reconstructive procedures; ReGenerCell for chronic wounds including leg and foot ulcers; and ReNovaCell for aesthetic applications including the restoration of pigmentation. Avita Medical distributes its products through its direct sales force in Australia and through distributors in the UK, France, Germany, Austria, Switzerland, Turkey, China, Japan, Taiwan, Saudi Arabia, South Korea and the US. Avita Medical is headquartered in London, the UK.

Scope

Detailed information on Avita Medical Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Avita Medical Ltd in the form of a SWOT analysis

An in-depth view of the business model of Avita Medical Ltd including a breakdown and examination of key business segments

News about Avita Medical Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Avita Medical Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Avita Medical Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Avita Medical Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Smith & Nephew Plc

Probiotec Ltd

Pfizer SA de CV

Organogenesis Inc

Living Cell Technologies Ltd

Johnson & Johnson

Alchemia Ltd

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Avita Medical Ltd - Key Facts 6

Avita Medical Ltd - Key Employees 7

Avita Medical Ltd - Key Employee Biographies 8

Avita Medical Ltd - Major Products and Services 9

Avita Medical Ltd - History 10

Avita Medical Ltd - Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Joint Venture 14

Section 2 Company Analysis 15

Company Overview 15

Avita Medical Ltd - Business Description 16

Geographical Segment: Americas (including Canada) 16

Performance 16

Geographical Segment: Asia Pacific 16

Performance 16

Geographical Segment: EMEA 16

Performance 16

R&D Overview 16

Avita Medical Ltd - Corporate Strategy 17

Avita Medical Ltd - SWOT Analysis 18

SWOT Analysis - Overview 18

Avita Medical Ltd - Strengths 18

Avita Medical Ltd - Weaknesses 19

Avita Medical Ltd - Opportunities 20

Avita Medical Ltd - Threats 21

Avita Medical Ltd - Key Competitors 22

Section 3 Company Financial Ratios 23

Financial Ratios - Capital Market Ratios 23

Financial Ratios - Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios - Interim Ratios 27

Financial Ratios - Ratio Charts 28

Section 4 Company’s Lifesciences Financial Deals and Alliances 29

Avita Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 29

Avita Medical Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018 30

Avita Medical Ltd, Recent Deals Summary 31

Section 5 Company’s Recent Developments 32

Jul 31, 2018: AVITA Medical Fourth Quarter 2018 Quarterly Cash Flow Report and Company Update 32

Mar 19, 2018: AVITA Medical: Appointment / Resignation of Company Secretary and Change in Registered Office 34

Feb 21, 2018: RenovaCare Secures Patent Victory and Continues to Bolster IP Portfolio 35

Jan 31, 2018: Avita Medical Second Quarter 2018 Quarterly Cash Flow Report and Company Update 36

Dec 20, 2017: Avita Medical receives decision on Inter Partes Review (IPR) petition of RenovaCare patent 38

Dec 05, 2017: Avita Announces New Chief Financial Officer; Existing CFO Moves to Chief Administrative Officer 39

Nov 29, 2017: Avita Announces Office Transitions in Australia and the UK 40

Aug 31, 2017: Avita Medical Names Erin Liberto as Chief Commercial Officer 41

Jun 02, 2017: Dr Michael S. Perry appointed Avita Medical CEO 42

May 10, 2017: Avita Medical Initiates Legal Proceedings to Cancel Renovacare Patent 43

Section 6 Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Tables

List of Tables

Avita Medical Ltd, Key Facts 6

Avita Medical Ltd, Key Employees 7

Avita Medical Ltd, Key Employee Biographies 8

Avita Medical Ltd, Major Products and Services 9

Avita Medical Ltd, History 10

Avita Medical Ltd, Other Locations 13

Avita Medical Ltd, Subsidiaries 13

Avita Medical Ltd, Joint Venture 14

Avita Medical Ltd, Key Competitors 22

Avita Medical Ltd, Ratios based on current share price 23

Avita Medical Ltd, Annual Ratios 24

Avita Medical Ltd, Annual Ratios (Cont…1) 25

Avita Medical Ltd, Interim Ratios 27

Avita Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 29

Avita Medical Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018 30

Avita Medical Ltd, Recent Deals Summary 31

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 47

Efficiency Ratios 47

List of Figures

List of Figures

Avita Medical Ltd, Performance Chart (2014 – 2018) 26

Avita Medical Ltd, Ratio Charts 28

Avita Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 29

Avita Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 30

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports